Chief Medical Officer at Dubai Medical University Hospital and Vice President of the Société Internationale d’Urologie (SIU), Immediate Past President of the Urological Association of Asia (UAA), and Executive Director of the Arab Association of Urology (AAU). He is Chairman of the Arab School of Urology, Professor of Urology at Tanta University in Egypt, and Senior Consultant Urologist at Sheikh Khalifa General Hospital, UAE. A Fellow of both the Royal College of Surgeons (UK) and the European Board of Urology (FEBU), Dr. Farahat specializes in minimally invasive surgery, endourology, robotic-assisted FURS, and andrology. He is a recognized researcher and international speaker, with numerous awards and over 35 publications to his name.
MS .FAAHPM. PhD Student (University of Maryland), Clinical Associate Professor Cleveland Clinic Lerner College of Medicine (CCLCM) of Case Western ReserveUniversity ,Staff Physician |Institute of Oncology |Cleveland Clinic Abu Dhabi | UAE, Section Head, Palliative & Supportive Care. Consultant in Palliative, Geriatric, and Internal Medicine, US Board Certified in all three specialties.
Professor and Medical Oncologist at Tata Memorial Hospital, Mumbai, with over two decades of experience. President and Convener of the Indian Cooperative Oncology Network (ICON). Has published over 100 research articles and led more than 80 projects as Principal or Co-Investigator. Founder of the Lung Cancer Consortium Asia, with 17 dedicated publications in the field and a strong commitment to lung cancer awareness and patient care.
Professor of Medical Oncology at Tata Memorial Hospital, Mumbai. MBBS and oncology-trained at AIIMS, New Delhi. Principal or Co-Investigator on over 100 clinical trials and author of 60+ peer-reviewed publications. Editor-in-Chief of the Indian Journal of Medical and Pediatric Oncology and General Secretary of the Women’s Cancer Initiative. Member of the ICMR Task Force on cervical cancer guidelines.
Dr Nag is the Director Oncology at the Sahaydri-Manipal Hospitals, Pune, Consultant Breast Oncologist, Breast Centre, Ruby Hall Clinic, Pune, Chairperson Ethics Committee, BALCO cancer hospital, Raipur, Managing Trustee, Nag Foundation – a NGO committed to cancer care, research and education. She did fellowships in Medical Oncology at Tata Memorial Hospital and Bombay Hospital, Mumbai and St George Hospital, Sydney. Her speciality is Breast and Gynaecological malignancies. Dr. Nag has recently completed an advanced certificate in molecular oncology from Thomas Jerfferson Institute, USA
Senior Director of Medical Oncology at Fortis Memorial Research Institute, Gurugram. Fellow of the Royal Society of Medicine, trained in medical oncology, palliative medicine, and teenage and young adult cancers in the UK. Formerly at the London Oncology Clinic, Harley Street. Specialist in metastatic breast cancer with a research focus on endocrine resistance mechanisms. Chief Investigator on multiple Phase II/III trials and a leading advocate for quality of life in cancer care.
Khaled Al Qawasmeh is a Clinical Research Nurse Professional, Hematology/Oncology at Tawam Hospital and Vice-President of Emirates Oncology & Hematology Nursing Society. Dr. Al Qawasmeh qualified with a master’s in clinical Oncology Nursing from the University of Pennsylvania, Philadelphia, USA. He is an Oncology Certified Nurse (OCN) as of 2009. Dr. Al Qawasmeh has gained the prestigious Clinical Research Certification from USA and become a Certified Clinical Research Professional (CCRP) 2015.
Dr. Wafaa Ayesh is President of MEAPEN and President of the PEN Society for Parenteral and Enteral Nutrition from 2025–2028). She is a highly respected Consultant Clinical Dietitian based in Dubai, with more than 30 years of leadership experience in clinical nutrition across the UAE and the Middle East. She is widely recognized for establishing the Clinical Nutrition Department at Dubai Health Authority (DHA) and serving as its long-standing Director. Currently, she practices as a Consultant Clinical Dietitian at Al Tadawi Specialty Hospital in Dubai, continuing to advance excellence in clinical nutrition and patient care throughout the region.
Consultant Oncoplastic Breast Surgeon at Mediclinic Middle East, Dubai. Brings over 20 years of experience from the UK, UAE, and India, including 15 years of training and practice in the UK. Recipient of the coveted Donald McNeill Oncoplastic Fellowship by the Association of Breast Surgeons UK, Fellow of the Royal College of Surgeons (UK), and Faculty at the Royal College of Surgeons of Edinburgh. Has conducted extensive research at University College London on DNA replication markers as prognostic and predictive factors in breast cancer, with publications in multiple peer-reviewed journals and an active presence as faculty at international conferences.
Consultant Interventional Radiologist with extensive UK-based experience in vascular and non-vascular intervention. Procedures include peripheral vascular angioplasties, hepato-biliary drainage and stenting, selective embolisations, and CT/ultrasound-guided biopsies. Fellowship-trained in Interventional Radiology at University Hospitals Network, Toronto, and a member of the British Society of Interventional Radiologists.
Consultant Breast Radiologist at Mediclinic City Hospital, Dubai. A University of the Witwatersrand, Johannesburg graduate, she holds a Fellowship of the College of South African Radiologists and a Diplomate in Anaesthesia. Prior to Dubai, she was a dedicated breast consultant at The Bone and Breast Care Centre, Johannesburg. In 2008, she established the first dedicated breast imaging unit at Mediclinic City Hospital, introducing image-guided breast interventions and spearheading the hospital’s multidisciplinary team meetings.
Consultant Medical Oncologist at HCA Healthcare, London, and Founding Medical Director of the Sarah Cannon Research Institute UK. Fellow of the Royal College of Physicians, trained at Hanover Medical School and the Royal Marsden Hospital. A key opinion leader in gastrointestinal cancers, drug development, and immunotherapy, with a portfolio of over 80 early clinical trials. Regular invited speaker at ASCO, ESMO, and AACR, with publications in the Lancet, Journal of Clinical Oncology, and Annals of Oncology.
Consultant ENT and Head & Neck Surgeon at Burjeel Cancer Institute, UAE. Trained in Rhinology Surgery at Tufts University, Boston, and completed further clinical training in Head & Neck, Thyroid-Parathyroid, Microvascular Reconstruction, and Robotic Surgery at Kansas University, USA. Holds the American Head & Neck Surgery certification and is a Fellow of the American College of Surgeons. Previously served as a visiting physician in Rhinology and Skull-Base Surgery at the University of Pennsylvania and the University of North Carolina. Areas of specialization include advanced sinus and skull-base surgery, thyroid and parathyroid endocrine surgery, and pediatric ENT.
Director of the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) at the Tata Memorial Centre in Mumbai. Head and Neck Cancer Surgeon at Tata Memorial Hospital, Mumbai. Trained in General Surgery at Banaras Hindu University and in Surgical Oncology at Tata Memorial Hospital. Member of the ICMR Taskforce on Oral Cancer and a founding member of the SAARC Federation of Oncology.
Shailesh V. Shrikhande is the Chief Executive of Tata Cancer Care Foundation (TCCF), Director of GI and HPB Cancer Surgery at Gleneagles Hospital, Parel, Mumbai, and a Consultant Surgeon at Breach Candy Hospital and Shrikhande Clinic, Mumbai, India. He is also the Officer on Special Duty at Tata Memorial Centre. Previously, he was Head of GI and HPB Surgery (2010-2025) and Deputy Director of Tata Memorial Hospital (2018-2025), Mumbai.
Consultant Medical Oncologist specializing in GI and breast cancers, and Medical Director of BALCO Medical Centre. Trained at Tata Memorial Centre, Mumbai and the Royal Marsden NHS Foundation Trust, UK. Her research focuses on breast and HPB cancers, survivorship, and quality oncology care in low- and middle-income countries. Honorary Consultant at Queen Mary’s University, London, and recipient of multiple awards including the Royal Marsden Award for Excellence and the LBF Visionary Award.
Dr. Shaheenah Dawood, MBBCh, FRCP (Glasgow), FRCP (Edin.), FACP, MPH is a Medical Oncologist and Professor of Clinical Oncology in the UAE. With over 100 publications, including over 50 original peer‑reviewed articles, she is a recognized Key Opinion Leader in the field of Oncology. She heads the Oncology Clinical Trials program at Mediclinic City Hospital in Dubai and serves as President of the Excellence in Oncology Care (EIOC) congress. Dr. Shaheenah is also Co‑Chair of APBCS, APGCS, BPOF and the Young Women’s Forum.